fludarabine has been researched along with Bone Marrow Failure Syndromes, Congenital in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abujoub, R; Alafghani, S; Aldaama, S; Almanjomi, F; Alsudairy, R; Alsultan, A; Ballourah, W; Essa, MF; Jarrar, MS; Memon, S | 1 |
Bajwa, RP; Rose, MJ; Woods, G | 1 |
1 review(s) available for fludarabine and Bone Marrow Failure Syndromes, Congenital
Article | Year |
---|---|
Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Blood Platelets; Congenital Bone Marrow Failure Syndromes; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Melphalan; Methylprednisolone; Mucositis; Neutrophils; Thrombocytopenia; Transplantation Conditioning; Vidarabine | 2014 |
1 other study(ies) available for fludarabine and Bone Marrow Failure Syndromes, Congenital
Article | Year |
---|---|
Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Congenital Bone Marrow Failure Syndromes; Cyclophosphamide; DNA Helicases; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; HLA Antigens; Humans; Male; Transplantation Conditioning | 2023 |